Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shanghai - Delayed Quote CNY

Jointown Pharmaceutical Group Co., Ltd (600998.SS)

Compare
4.7700
-0.0100
(-0.21%)
At close: 3:00:04 PM GMT+8
Currency in CNY All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
149,204,637.6211
150,139,846.7358
140,424,191.6274
122,407,434.0230
110,859,514.0880
Cost of Revenue
137,342,812.0777
138,028,963.1276
129,476,178.1711
112,569,808.2243
100,919,393.3760
Gross Profit
11,861,825.5434
12,110,883.6082
10,948,013.4563
9,837,625.7987
9,940,120.7120
Operating Expense
7,613,608.7549
7,573,749.1118
6,951,938.9432
6,361,028.8032
5,861,048.9222
Operating Income
4,248,216.7885
4,537,134.4964
3,996,074.5130
3,476,596.9955
4,079,071.7898
Net Non Operating Interest Income Expense
-1,143,025.2582
-1,174,293.6799
-1,116,574.8408
-1,090,949.2479
-983,722.1974
Pretax Income
2,903,755.8989
2,990,863.2999
2,838,087.0618
3,363,264.1170
4,334,018.3076
Tax Provision
720,357.0736
701,202.2242
552,554.1250
754,882.1630
948,935.8596
Net Income Common Stockholders
2,046,550.6712
2,174,042.8384
2,084,962.5398
2,448,334.1829
3,075,054.8238
Basic EPS
0.41
0.43
0.40
0.47
0.59
Diluted EPS
0.41
0.43
0.40
0.47
0.58
Basic Average Shares
5,041,376.0720
5,099,118.6570
5,273,728.7770
5,187,653.8470
5,171,742.5170
Diluted Average Shares
5,041,376.0720
5,099,118.6570
5,273,728.7770
5,187,653.8470
5,338,572.9210
Total Operating Income as Reported
2,917,448.7954
3,022,717.9319
2,853,085.5307
3,592,626.8575
4,352,380.2298
Rent Expense Supplemental
--
85,133.6864
77,068.2729
83,477.8001
198,213.8665
Total Expenses
144,956,420.8325
145,602,712.2394
136,428,117.1144
118,930,837.0275
106,780,442.2982
Net Income from Continuing & Discontinued Operation
2,046,550.6712
2,174,042.8384
2,084,962.5398
2,448,334.1829
3,075,054.8238
Normalized Income
2,244,750.5900
2,449,336.2499
2,326,172.9156
1,627,801.0430
2,190,972.7440
Interest Income
177,004.2686
222,760.8287
192,137.6136
140,214.3349
148,600.3721
Interest Expense
1,266,599.4036
1,317,637.8604
1,221,465.8166
1,145,268.2303
1,027,444.0574
Net Interest Income
-1,143,025.2582
-1,174,293.6799
-1,116,574.8408
-1,090,949.2479
-983,722.1974
EBIT
4,170,355.3025
4,308,501.1603
4,059,552.8784
4,508,532.3473
5,361,462.3649
EBITDA
4,170,355.3025
5,083,446.0002
4,795,835.2400
5,165,341.1852
5,875,796.0530
Reconciled Cost of Revenue
137,342,812.0777
138,028,963.1276
129,476,178.1711
112,569,808.2243
100,919,393.3760
Reconciled Depreciation
--
774,944.8399
736,282.3616
656,808.8379
514,333.6881
Net Income from Continuing Operation Net Minority Interest
2,046,550.6712
2,174,042.8384
2,084,962.5398
2,448,334.1829
3,075,054.8238
Total Unusual Items Excluding Goodwill
-263,590.9558
-359,601.2396
-299,525.7849
1,058,000.5977
1,131,915.6854
Total Unusual Items
-263,590.9558
-359,601.2396
-299,525.7849
1,058,000.5977
1,131,915.6854
Normalized EBITDA
4,433,946.2584
5,443,047.2398
5,095,361.0249
4,107,340.5876
4,743,880.3676
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
-65,391.0370
-84,307.8281
-58,315.4091
237,467.4578
247,833.6056
12/31/2020 - 11/2/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade